Cytokinetics CEO Robert I. Blum disposes of USD 490,950 in common shares
Bitget2026/09/28 20:55- Cytokinetics President and CEO Robert I. Blum exercised stock options for 7,500 shares at USD 10.6 on Sept. 28, 2026.
- Blum sold 7,500 shares at USD 65.46 the same day.
- Directly held common shares totaled 278,544 following the transactions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Besent “Extinguishes Fire”: Rising US Treasury yields are a global phenomenon, dismisses concerns over AI bubble
U.S. Treasury Secretary Janet Yellen defended the rise in U.S. Treasury yields, stating that this increase is a global phenomenon rather than unique to the United States, and does not warrant excessive concern. She partially attributed inflationary pressures to higher oil prices caused by the Iran conflict, and expects the energy shock to subside as hostilities ease. Yellen refuted the notion of an AI bubble, arguing that investments by major tech companies are grounded in solid business logic.
Bitcoin Crash Warning Goes Viral as X Post Flags Benner Cycle
Crypto prices
More
